ישראל - עברית - Ministry of Health

bayer israel ltd - ibritumomab tiuxetan 1.6 mg/ml - kit for radiopharmaceutical preparation infusion - ibritumomab tiuxetan(90y) - the 90y radiolabelled zevalin is indicated as consolidation therapy after remission induction in previously untreated patients with follicular lymphoma. the benefit of zevalin following rituximab in combination with chemotherapy has not been established.the 90y - radiolabelled zevalin is indicated for the treatment of adult patients with rituximab relapsed or refractory cd20+ follicular b-cell non-hodgkin's lymphama ( nhl).

ישראל - עברית - Ministry of Health

novartis israel ltd - ranibizumab - תמיסה להזרקה - ranibizumab 10 mg/ml - ranibizumab - ranibizumab - treatment of patients with neovascular (wet) age-related macular degeneration (amd).treatment of adult patients with visual impairment due to diabetic macular oedema (dme) .the treatment of visual impairement due to macular oedema secondary to retinal vein occulsion (rvo).the treatment of visual impaiment due to choroidal neovacularization (cnv) secondary to pathologic myopia (pm).

ישראל - עברית - Ministry of Health

vitamed pharmaceutical industries ltd - amoxicillin as trihydrate; clavulanic acid as potassium - תרחיף - clavulanic acid as potassium 62.5 mg / 5 ml; amoxicillin as trihydrate 250 mg / 5 ml - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - lower respiratory infections, otitis media, sinusitis, acute pharyngitis, urinary tract infections, skin and soft tissue infections caused by beta-lactamase producing organisms susceptible to amoxycillin and clavulanic acid.

ישראל - עברית - Ministry of Health

takeda israel ltd - factor viii inhibitor bypassing fraction - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - factor viii inhibitor bypassing fraction 500 u/vial - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - for the control of bleeding episodes in haemophilia a patients with factor viii inhibitors and also in patients with acquired factor viii inhibitors.

ישראל - עברית - Ministry of Health

takeda israel ltd - factor viii inhibitor bypassing fraction - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - factor viii inhibitor bypassing fraction 1000 u/vial - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - for the control of bleeding episodes in haemophilia a patients with factor viii inhibitors and also in patients with acquired factor viii inhibitors .

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - tibolone - טבליה - tibolone 2.5 mg - tibolone - tibolone - complaints resulting from the natural or artificial menopause. prevention of osteoporosis in estrogen deficiency states. treatment of estrogen deficiency symptoms in postmenopausal women.

ישראל - עברית - Ministry of Health

j-c health care ltd - ibrutinib - טבליות מצופות פילם - ibrutinib 140 mg - ibrutinib

ישראל - עברית - Ministry of Health

j-c health care ltd - ibrutinib - טבליות מצופות פילם - ibrutinib 280 mg - ibrutinib

ישראל - עברית - Ministry of Health

j-c health care ltd - ibrutinib - טבליות מצופות פילם - ibrutinib 420 mg - ibrutinib

ישראל - עברית - Ministry of Health

j-c health care ltd - ibrutinib - טבליות מצופות פילם - ibrutinib 560 mg - ibrutinib